GlaxoSmithKline Plc (GSK.L, GSK) reported fiscal 2021 adjusted operating profit of 8.81 billion pounds, 1% lower than 2020 at AER, but 9% higher at CER on a turnover increase of 5% CER. The company said the increase in adjusted operating profit primarily reflected the benefit from incremental pandemic sales, sales growth in Pharmaceuticals and tight control of ongoing costs, favourable legal settlements and benefits from continued restructuring across the business. Adjusted earnings per share was 113.2 pence compared to 115.9 pence, previous year, down 2% AER but up 9% CER.
from RTT - Earnings https://ift.tt/GOmeXa3
via IFTTT
No comments:
Post a Comment